For: | Mottershead M, Neuberger J. Transplantation in autoimmune liver diseases. World J Gastroenterol 2008; 14(21): 3388-3395 [PMID: PMC2716593 DOI: 10.3748/wjg.14.3388] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v14/i21/3388.htm |
Number | Citing Articles |
1 |
Rodrigo Liberal, Giorgina Mieli-Vergani, Diego Vergani. Contemporary issues and future directions in autoimmune hepatitis. Expert Review of Gastroenterology & Hepatology 2016; 10(10): 1163 doi: 10.1080/17474124.2016.1193004
|
2 |
N. Kemmer, G. Neff. Recipient-Based Approach to Tailoring Immunosuppression in Liver Transplantation. Transplantation Proceedings 2010; 42(5): 1731 doi: 10.1016/j.transproceed.2010.02.076
|
3 |
Monica El-Masry, Carlos Puig Gilbert, Sammy Saab. Recurrence of non-viral liver disease after orthotopic liver transplantation. Liver International 2011; 31(3): 291 doi: 10.1111/j.1478-3231.2010.02434.x
|
4 |
Gideon M Hirschfield, E Jenny Heathcote. Evidence‐Based Gastroenterology and Hepatology. 2010; : 508 doi: 10.1002/9781444314403.ch32
|
5 |
E. Ben George, G. Jeba Rosline, Abraham Varghese, Rajesh D. Gnana. Classification Framework for Autoimmune Liver Disease using Machine Learning and Deep Learning Techniques. 2024 5th Technology Innovation Management and Engineering Science International Conference (TIMES-iCON) 2024; : 1 doi: 10.1109/TIMES-iCON61890.2024.10630757
|
6 |
S. E. Voskanyan, V. E. Syutkin, A. I. Sushkov, Yu. V. Voskanyan, A. Yu. Veselkova. Liver allograft pathology in the late post-transplant period. Transplantologiya. The Russian Journal of Transplantation 2023; 15(3): 359 doi: 10.23873/2074-0506-2023-15-3-359-375
|
7 |
Nader Dbouk, Samir Parekh. Impact of pretransplant antinuclear antibody and antismooth muscle antibody titers on disease recurrence and graft survival following liver transplantation in autoimmune hepatitis patients. Journal of Gastroenterology and Hepatology 2013; 28(3): 537 doi: 10.1111/j.1440-1746.2012.07125.x
|
8 |
|
9 |
|
10 |
Giorgina Mieli-Vergani, Diego Vergani, Albert J. Czaja, Michael P. Manns, Edward L. Krawitt, John M. Vierling, Ansgar W. Lohse, Aldo J. Montano-Loza. Autoimmune hepatitis. Nature Reviews Disease Primers 2018; 4(1) doi: 10.1038/nrdp.2018.17
|
11 |
Flavia Mendes, Claudia A. Couto, Cynthia Levy. Recurrent and De Novo Autoimmune Liver Diseases. Clinics in Liver Disease 2011; 15(4): 859 doi: 10.1016/j.cld.2011.08.008
|
12 |
Briton Lee, Edward W. Holt, Robert J. Wong, Justin L. Sewell, Ma Somsouk, Mandana Khalili, Jacquelyn J. Maher, Michele M. Tana. Race/ethnicity is an independent risk factor for autoimmune hepatitis among the San Francisco underserved. Autoimmunity 2018; 51(5): 258 doi: 10.1080/08916934.2018.1482884
|
13 |
Rodrigo Liberal, Charlotte R. Grant, Giorgina Mieli-Vergani, Diego Vergani. Autoimmune hepatitis: A comprehensive review. Journal of Autoimmunity 2013; 41: 126 doi: 10.1016/j.jaut.2012.11.002
|
14 |
Nurmeen Adil, Amna Jabbar Siddiqui, Syed Ghulam Musharraf. Metabolomics‐based researches in autoimmune liver disease: A mini‐review. Scandinavian Journal of Immunology 2022; 96(4) doi: 10.1111/sji.13208
|
15 |
Hanlin L. Wang, Christopher D. Anderson, Sean Glasgow, William C. Chapman, Jeffrey S. Crippin, Mathew Augustine, Robert A. Anders, Andres Roma. Pathology of Solid Organ Transplantation. 2009; : 199 doi: 10.1007/978-3-540-79343-4_8
|
16 |
Sara Hafezi-Bakhtiari, Oyedele A. Adeyi. Evaluating and interpreting bile duct changes in liver allograft biopsies. Diagnostic Histopathology 2012; 18(2): 86 doi: 10.1016/j.mpdhp.2011.11.001
|
17 |
James Neuberger. Disease Recurrence After Liver Transplantation. 2016; : 91 doi: 10.1007/978-1-4939-2947-4_6
|
18 |
Gary C. Kanel, Jacob Korula. Atlas of Liver Pathology. 2011; : 321 doi: 10.1016/B978-1-4377-0765-6.10011-4
|
19 |
V. E. Syutkin, A. A. Salienko, O. D. Olisov, M. S. Novruzbekov. Relapse of autoimmune diseases after liver transplantation. Transplantologiya. The Russian Journal of Transplantation 2022; 14(4): 421 doi: 10.23873/2074-0506-2022-14-4-421-431
|
20 |
Steven Zacks. Diagnosis and Management of Autoimmune Hepatitis. 2020; : 125 doi: 10.1007/978-3-030-33628-8_9
|
21 |
Rodrigo Liberal, Charlotte R Grant. Cirrhosis and autoimmune liver disease: Current understanding. World Journal of Hepatology 2016; 8(28): 1157-1168 doi: 10.4254/wjh.v8.i28.1157
|
22 |
Yao Chen, Fang Luo, Shiqiao Luo, Zhongjun Wu, Jian Zhou. The augmenter of liver regeneration protects the kidneys after orthotopic liver transplantation possibly by upregulating HIF-1α and O2-sensitive K+ channels. Surgery Today 2011; 41(3): 382 doi: 10.1007/s00595-010-4282-4
|
23 |
Katsuya Toshida, Takeo Toshima, Noboru Harada, Yuki Nakayama, Takahiro Tomiyama, Akinari Morinaga, Yukiko Kosai-Fujimoto, Takahiro Tomino, Takeshi Kurihara, Yoshihiro Nagao, Kazutoyo Morita, Shinji Itoh, Tomoharu Yoshizumi. Autoimmune Hepatitis in an Immunosuppression-Free Patient Who Underwent Living Donor Liver Transplantation From an Identical Twin: A Case Report. Transplantation Proceedings 2022; 54(10): 2791 doi: 10.1016/j.transproceed.2022.09.022
|
24 |
R. Liberal, G. Mieli-Vergani, D. Vergani. Autoimmune hepatitis: From mechanisms to therapy. Revista Clínica Española 2016; 216(7): 372 doi: 10.1016/j.rce.2016.04.003
|
25 |
David M. Chascsa, Hugo E. Vargas. The Gastroenterologist's Guide to Management of the Post-Liver Transplant Patient. American Journal of Gastroenterology 2018; 113(6): 819 doi: 10.1038/s41395-018-0049-0
|
26 |
Chongfa Chen, Ruisheng Ke, Fang Yang, Qiucheng Cai, Jianyong Liu, Xinghua Huang, Jianwei Chen, Fengfeng Xu, Yi Jiang. Risk factors for recurrent autoimmune liver diseases after liver transplantation. Medicine 2020; 99(20): e20205 doi: 10.1097/MD.0000000000020205
|
27 |
Martina Bruna Violatto, Elisabetta Casarin, Laura Talamini, Luca Russo, Simone Baldan, Camilla Tondello, Marie Messmer, Edith Hintermann, Alessandro Rossi, Alice Passoni, Renzo Bagnati, Stefania Biffi, Chiara Toffanin, Sara Gimondi, Stefano Fumagalli, Maria-Grazia De Simoni, Donatella Barisani, Mario Salmona, Urs Christen, Pietro Invernizzi, Paolo Bigini, Margherita Morpurgo. Dexamethasone Conjugation to Biodegradable Avidin-Nucleic-Acid-Nano-Assemblies Promotes Selective Liver Targeting and Improves Therapeutic Efficacy in an Autoimmune Hepatitis Murine Model. ACS Nano 2019; 13(4): 4410 doi: 10.1021/acsnano.8b09655
|
28 |
Pietro Invernizzi, Patrick S. C. Leung, Xiong Ma, M. Eric Gershwin. Liver Immunology. 2014; : 253 doi: 10.1007/978-3-319-02096-9_18
|
29 |
Rahima A. Bhanji, Andrew L. Mason, Safwat Girgis, Aldo J. Montano‐Loza. Liver transplantation for overlap syndromes of autoimmune liver diseases. Liver International 2013; 33(2): 210 doi: 10.1111/liv.12027
|
30 |
AnJi Xiong, SuTing Li, XiaoYan Dou, YuFeng Yao. Cyclophosphamide in refractory autoimmune hepatitis and autoimmune hepatitis coexisting extrahepatic autoimmune disorders. The American Journal of the Medical Sciences 2024; 368(5): 446 doi: 10.1016/j.amjms.2024.06.007
|
31 |
Rodrigo Liberal, Yoh Zen, Giorgina Mieli-Vergani, Diego Vergani. Liver transplantation and autoimmune liver diseases. Liver Transplantation 2013; 19(10): 1065 doi: 10.1002/lt.23704
|
32 |
A. J. Montano-Loza, R. A. Bhanji, S. Wasilenko, A. L. Mason. Systematic review: recurrent autoimmune liver diseases after liver transplantation. Alimentary Pharmacology & Therapeutics 2017; 45(4): 485 doi: 10.1111/apt.13894
|
33 |
H. Sakai, K. Ishiyama, Y. Tanaka, K. Ide, M. Ohira, H. Tahara, T. Abe, F. Hirata, H. Morimoto, S. Hashimoto, N. Tanimine, Y. Saeki, S. Shimizu, T. Yano, T. Kobayashi, H. Tashiro, H. Ohdan. Potential Benefit of Mixed Lymphocyte Reaction Assay-based Immune Monitoring After Living Donor Liver Transplantation for Recipients With Autoimmune Hepatitis. Transplantation Proceedings 2014; 46(3): 785 doi: 10.1016/j.transproceed.2013.11.123
|
34 |
O Adeyi, S E Fischer, M Guindi. Liver allograft pathology: approach to interpretation of needle biopsies with clinicopathological correlation. Journal of Clinical Pathology 2010; 63(1): 47 doi: 10.1136/jcp.2009.068254
|
35 |
Yan-Tian Xu, De-Jie Liu, Fan-Ying Meng, Guang-Bing Li, Jun Liu. Possible benefit of splenectomy in liver transplantation for autoimmune hepatitis. Hepatobiliary & Pancreatic Diseases International 2014; 13(3): 328 doi: 10.1016/S1499-3872(14)60256-3
|
36 |
Nabiha Faisal, Eberhard L Renner. Recurrence of autoimmune liver diseases after liver transplantation. World Journal of Hepatology 2015; 7(29): 2896-2905 doi: 10.4254/wjh.v7.i29.2896
|
37 |
Pietro Invernizzi. Geoepidemiology of autoimmune liver diseases. Journal of Autoimmunity 2010; 34(3): J300 doi: 10.1016/j.jaut.2009.12.002
|
38 |
Varun Saxena, Norah A. Terrault. Zakim and Boyer's Hepatology. 2018; : 784 doi: 10.1016/B978-0-323-37591-7.00053-7
|
39 |
Ningning Yang, Manrong Jiang. Emerging Trends in Cell and Gene Therapy. 2013; : 411 doi: 10.1007/978-1-62703-417-3_18
|
40 |
Aldo J. Montano-Loza, Andrew L. Mason, Mang Ma, Ravin J. Bastiampillai, Vincent G. Bain, Puneeta Tandon. Risk factors for recurrence of autoimmune hepatitis after liver transplantation. Liver Transplantation 2009; 15(10): 1254 doi: 10.1002/lt.21796
|
41 |
Patrick G. Jackson, Steven R.T. Evans. Sabiston Textbook of Surgery. 2012; : 1476 doi: 10.1016/B978-1-4377-1560-6.00055-X
|
42 |
Katrin Hoffmann, Ulf Hinz, Norbert Hillebrand, Tom Ganten, Daniel Gotthardt, Thomas Longerich, Peter Schirmacher, Peter Schemmer. The MELD score predicts the short-term and overall survival after liver transplantation in patients with primary sclerosing cholangitis or autoimmune liver diseases. Langenbeck's Archives of Surgery 2014; 399(8): 1001 doi: 10.1007/s00423-014-1237-z
|
43 |
Utz Settmacher, Falk Rauchfuß, Michael Bauer, Astrid Bauschke, Susanne Beckebaum, Alfred Königsrainer, Christina Malessa, Silvio Nadalin, Silke Rummler, Andreas Kortgen, Lara Genedy. Organtransplantation mit Lebendspende. 2023; : 129 doi: 10.1007/978-3-662-65736-2_8
|
44 |
Randeep Kashyap, Saman Safadjou, Rui Chen, Parvez Mantry, Rajeev Sharma, Vrishali Patil, Manoj Maloo, Charlotte Ryan, Carlos Marroquin, Christopher Barry, Gopal Ramaraju, Benedict Maliakkal, Mark Orloff. Living Donor and Deceased Donor Liver Transplantation for Autoimmune and Cholestatic Liver Diseases—An Analysis of the UNOS Database. Journal of Gastrointestinal Surgery 2010; 14(9): 1362 doi: 10.1007/s11605-010-1256-1
|
45 |
Tomohiro Tanaka, Yasuhiko Sugawara, Norihiro Kokudo. Liver transplantation and autoimmune hepatitis. Intractable & Rare Diseases Research 2015; 4(1): 33 doi: 10.5582/irdr.2014.01034
|
46 |
Claire Kelly, Yoh Zen, Michael A. Heneghan. Post-Transplant Immunosuppression in Autoimmune Liver Disease. Journal of Clinical and Experimental Hepatology 2023; 13(2): 350 doi: 10.1016/j.jceh.2022.07.002
|
47 |
Sanjaya K. Satapathy, Ollie D. Jones, Jason M. Vanatta, Faisal Kamal, Satish K. Kedia, Yu Jiang, Satheesh P. Nair, James D. Eason. Outcomes of Liver Transplant Recipients With Autoimmune Liver Disease Using Long-Term Dual Immunosuppression Regimen Without Corticosteroid. Transplantation Direct 2017; 3(7): e178 doi: 10.1097/TXD.0000000000000693
|
48 |
R. Liberal, G. Mieli-Vergani, D. Vergani. Autoimmune hepatitis: From mechanisms to therapy. Revista Clínica Española (English Edition) 2016; 216(7): 372 doi: 10.1016/j.rceng.2016.04.004
|
49 |
David Uihwan Lee, Reid Ponder, Kijung Lee, Samantha Menegas, Gregory Hongyuan Fan, Harrison Chou, Daniel Jung, Keeseok Lee, David Jeffrey Hastie, Nathalie Helen Urrunaga. The differences in post-liver transplant outcomes of patients with autoimmune hepatitis who present with overlapping autoimmune liver diseases. Hepatology International 2023; 17(3): 720 doi: 10.1007/s12072-022-10468-8
|
50 |
Rodrigo Liberal, Maria Serena Longhi, Charlotte R. Grant, Giorgina Mieli–Vergani, Diego Vergani. Autoimmune Hepatitis After Liver Transplantation. Clinical Gastroenterology and Hepatology 2012; 10(4): 346 doi: 10.1016/j.cgh.2011.10.028
|